Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 6/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.55 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.53 |
| ▸ | ACE | P12821 | 1/20 | 0.51 |
| ▸ | GHSR | Q92847 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29511018 | 1.00 | KISS1R (0.58) | KISS1ROPRM1OPRD1IL23RACE | |
| SCHEMBL29476441 | 0.96 | KISS1R (0.55) | KISS1ROPRM1OPRD1IL23RACE | |
| SCHEMBL29476439 | 0.96 | KISS1R (0.55) | KISS1ROPRM1OPRD1IL23RACE | |
| SCHEMBL30264819 | 0.96 | KISS1R (0.55) | KISS1RIL23RACEGHSR | |
| SCHEMBL30264955 | 0.96 | KISS1R (0.55) | KISS1RIL23RACEGHSR | |
| SCHEMBL30264867 | 0.96 | KISS1R (0.55) | KISS1RIL23RACEGHSR | |
| SCHEMBL30264784 | 0.96 | KISS1R (0.55) | KISS1RIL23RACEGHSR | |
| SCHEMBL30786983 | 0.96 | KISS1R (0.53) | KISS1RACE | |
| SCHEMBL31184496 | 0.96 | KISS1R (0.53) | KISS1RACE | |
| SCHEMBL29476104 | 0.96 | KISS1R (0.53) | KISS1RACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085092-A1 | MELANOCORTIN RECEPTOR LIGANDS | IPSEN PHARMA SAS (FR) | 2026-03-26 | — | — | US | disclosed |
| US-20220339239-A1 | USE OF MELANOCORTINS TO TREAT INSULIN SENSITIVITY | IPSEN PHARMA SAS (FR) | 2022-10-27 | — | — | US | disclosed |
| US-20220127305-A1 | MELANOCORTIN RECEPTOR LIGANDS | IPSEN PHARMA SAS (FR) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085092-A1 | MELANOCORTIN RECEPTOR LIGANDS | THRB, MC1R, MC5R | KISS1R 417/4885OPRM1 25/4885OPRD1 19/4885 |
| US-20220339239-A1 | USE OF MELANOCORTINS TO TREAT INSULIN SENSITIVITY | MC4R, MC1R, MC3R | KISS1R 155/4885OPRM1 216/4885OPRD1 359/4885 |
| US-20220127305-A1 | MELANOCORTIN RECEPTOR LIGANDS | MC3R, MC1R, MC5R | KISS1R 232/4885OPRM1 115/4885OPRD1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.